VANCOUVER, BC AND LAS VEGAS, NV / ACCESS Newswire / December 22, 2025 / Ovation Science Inc. (CSE:OVAT)(OTC PINK:OVATF) ("Ovation" or the "Company") welcomes the recent U.S. rescheduling of cannabis ...
In comparative laboratory testing, Ovation's topicals achieved CBD bioavailability of 82%, compared to just 2-3% for competing topical products. By contrast, oral CBD products, such as gummies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results